NCT05537662View on ClinicalTrials.gov

External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO)

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 6, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

April 30, 2025

Conditions
Chronic Pain
Interventions
DEVICE

Standard of care neuromodulation therapy (SCS or DRG)

Standard SCS or DRG therapy

Trial Locations (1)

60612

RECRUITING

Rush University Medical Center, Chicago

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY